8th Annual Immuno-Oncology 360º: 5 Talks to Watch with IO360º Advisor Dan Chen

About the Episode:  Daniel Chen, MD, PhD, Immuno-Oncology 360º 2022 Strategic Advisor, Physician Scientist, Cancer Immunotherapy and Board of Directors, Society for Immunotherapy of Cancer (SITC) and co-author of the Cancer Immunity Cycle, discusses five talks he is excited for, and why, at the upcoming Immuno-Oncology360 conference. The 2022 summit will be held March 16th through the 18th, 2022 at the New York Marriott Brooklyn Bridge. For more information, and the full agenda, visit theconferenceforum.org.      The Talks Referenced:  "ctDNA Guiding Adjuvant Immunotherapy in Urothelial Carcinoma" ​​​​​​​Sanjeev Mariathasan, PhD, Genentech"Recent Clinical Data on PSMA BiTE® Molecule, AMG 160"  Margit Janát-Amsbury, MD, PhD, Amgen "Novel Approaches to Expand the Therapeutic Index of T cell Engagers" ​​​​​​​Holger Wesche, PhD, Harpoon Therapeutics​​​​​​​"Synthetic Biology as a Way to Make Better Cell Therapies"  moderated by Michael Kalos, PhD, Next Pillar Consulting, and Panelists Mark Kotter, MD, PhD, bit.bio; Nick Haining, MD, Arsenal Bio; and Celeste Richardson, PhD, Catamaran Bio"IO360° Cancer Immunotherapy Debate: NK-CARs vs T cell-CARs," ​​​​​​​Kristen Hege, MD, BMS, versus Bob Valamehr, PhD, MBA, Fate Therapeutics